# EDGAR Filing Document

**Accession Number:** 0001671338
**File Stem:** 0000950170-25-092203
**Filing Date:** 2025-7
**Character Count:** 11233
**Document Hash:** d9367e0a3819c1a63753511c5eb57281
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-092203.hdr.sgml**: 20250701

**ACCESSION NUMBER**: 0000950170-25-092203

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250701

**FILED AS OF DATE**: 20250701

**DATE AS OF CHANGE**: 20250701

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Ketcham Brian L
- **CENTRAL INDEX KEY:** 0001671338

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-13419
- **FILM NUMBER:** 251096514

**MAIL ADDRESS:**
- **STREET 1:** 2222 N 111TH STREET
- **CITY:** OMAHA
- **STATE:** NE
- **ZIP:** 68164
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LINDSAY CORP
- **CENTRAL INDEX KEY:** 0000836157
- **STANDARD INDUSTRIAL CLASSIFICATION:** FARM MACHINERY & EQUIPMENT [3523]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 470554096
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0831

**BUSINESS ADDRESS:**
- **STREET 1:** 18135 BURKE STREET
- **STREET 2:** SUITE 100
- **CITY:** OMAHA
- **STATE:** NE
- **ZIP:** 68022
- **BUSINESS PHONE:** 4028296800

**MAIL ADDRESS:**
- **STREET 1:** 18135 BURKE STREET
- **STREET 2:** SUITE 100
- **CITY:** OMAHA
- **STATE:** NE
- **ZIP:** 68022

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LINDSAY MANUFACTURING CO
- **DATE OF NAME CHANGE:** 19920703

## Ex-24

POWER OF ATTORNEY

KNOW ALL BY THESE PRESENTS that the undersigned hereby makes, constitutes, designates and appoints each of Eric Arneson and Ryan Loneman, signing singly, as the undersigned's true and lawful attorney-in-fact to act for and on behalf of the undersigned for and limited to the following purposes:

a. To execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Lindsay Corporation, a Delaware corporation (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules thereunder;

b. To do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any individual or group filings under Section 16(a) of the Exchange Act and timely file such forms with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

c. To take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to make filings under Section 16(a) of the Exchange Act with respect to the undersigned's holdings of the transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact and the Secretary of the Company.

IN WITNESS WHEREOF the undersigned has caused this Power of Attorney to be executed as of this 9th day of October, 2017.

/s/ Brian L. Ketcham

Brian L. Ketcham

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Ketcham Brian L<br><sub>(Last) (First) (Middle)</sub><br>18135 BURKE ST.<br>SUITE 100<br><sub>(Street)</sub><br>OMAHA, NE 68022<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-07-01 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Senior Vice President and CFO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>LINDSAY CORP [ LNN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-07-01 |  | M |  | 3999 | A | $78.23 | 13620<sup>(1)</sup> | D |  |
| Common Stock | 2025-07-01 |  | S |  | 3999 | D | 149.09<sup>(2)</sup> | 9621<sup>(1)</sup> | D |  |
| Common Stock |  |  |  |  |  |  |  | 1410 | I | By spouse<sup>(3)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Option to Purchase | $78.23 | 2025-07-01 |  | M |  |  | 3999 | 2020-11-01<sup>(4)</sup> | 2026-10-21 | Common Stock | 3999 | $0 | 0 | D |  |
| Option to Purchase | $121.16 |  |  |  |  |  |  | <sup>(5)</sup> | 2034-10-28 | Common Stock | 3851 |  | 3851 | D |  |
| Option to Purchase | $120.54 |  |  |  |  |  |  | <sup>(6)</sup> | 2033-10-23 | Common Stock | 2826 |  | 2826 | D |  |
| Option to Purchase | $156.16 |  |  |  |  |  |  | <sup>(7)</sup> | 2032-10-24 | Common Stock | 2251 |  | 2251 | D |  |
| Option to Purchase | $145.93 |  |  |  |  |  |  | 2024-11-01<sup>(8)</sup> | 2031-10-25 | Common Stock | 2538 |  | 2538 | D |  |
| Option to Purchase | $110.42 |  |  |  |  |  |  | 2023-11-01<sup>(9)</sup> | 2030-10-26 | Common Stock | 3015 |  | 3015 | D |  |
| Option to Purchase | $94.41 |  |  |  |  |  |  | 2022-11-01<sup>(10)</sup> | 2029-10-31 | Common Stock | 3825 |  | 3825 | D |  |
| Option to Purchase | $91.82 |  |  |  |  |  |  | 2021-11-01<sup>(11)</sup> | 2028-10-22 | Common Stock | 3743 |  | 3743 | D |  |
| Option to Purchase | $91.56 |  |  |  |  |  |  | 2021-11-01<sup>(12)</sup> | 2027-10-31 | Common Stock | 3840 |  | 3840 | D |  |

---

### Footnotes:

(1) Includes common stock in the form of restricted stock units.

(2) The price reported is the average trading price of the shares sold. The shares were sold in multiple transactions at prices ranging from $148.88 to $149.36, inclusive. Upon request, the reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

(3) Shares were purchased by, and are held in the name of, Mr. Ketcham's spouse.

(4) The option vested in four equal annual installments, which began on November 1, 2017.

(5) The option vests in three equal annual installments beginning on November 1, 2025.

(6) The option vests in three equal annual installments, which began on November 1, 2024.

(7) The option vests in three equal annual installments, which began on November 1, 2023.

(8) The option vested in three equal annual installments, which began on November 1, 2022.

(9) The option vested in three equal annual installments, which began on November 1, 2021.

(10) The option vested in three equal annual installments, which began on November 1, 2020.

(11) The option vested in three equal annual installments, which began on November 1, 2019.

(12) The option vested in four equal annual installments, which began on November 1, 2018.

**Signature:** /s/ Ryan Loneman, attorney-in-fact  
**Date:** 2025-07-01

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**